Lataa...
Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)—multiple rather than a single mechanism
Despite manifold efforts to achieve reduced-intensity and -toxicity regimens, secondary leukemia has remained the most severe side effect of chemotherapeutic cancer treatment. Rearrangements involving a short telomeric <1 kb region of the mixed lineage leukemia (MLL) gene are the most frequently...
Tallennettuna:
| Julkaisussa: | Front Cell Dev Biol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4479792/ https://ncbi.nlm.nih.gov/pubmed/26161385 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2015.00041 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|